Laboratory of Microbiology, Wageningen University & Research, Stippeneng 4, 6708 WE, Wageningen, The Netherlands.
Mead Johnson, Middenkampweg 2, 6545 CJ, Nijmegen, The Netherlands.
Sci Rep. 2024 Aug 14;14(1):18866. doi: 10.1038/s41598-024-69685-w.
Isomalto/malto-polysaccharides (IMMPs) are a novel type of soluble dietary fibres with a prebiotic potential promoting growth of beneficial microbes in the gut. However, the mode of action of IMMPs remains unknown. Previous studies on IMMPs showed an increase in total bacteria, especially lactobacilli, and higher production of short chain fatty acids (SCFA) when IMMPs were fed to rats or used during in vitro fermentation. Here we used metatranscriptomics to investigate how IMMPs with different amounts of α - (1 → 6) glycosidic linkages affected microbial function during incubation with human fecal inoculum. We showed that active microbial community dynamics during fermentation varied depending on the type of IMMP used and that the observed changes were reflected in the community gene expression profiles. Based on metatranscriptome analysis, members of Bacteroides, Lactobacillus and Bifidobacterium were the predominant degraders of IMMPs, and the increased gene expression in these bacteria correlated with high amounts of α - (1 → 6) glycosidic linkages. We also noted an increase in relative abundance of these bacteria and an activation of pathways involved in SCFA synthesis. Our findings could provide a baseline for more targeted approaches in designing prebiotics for specific bacteria and to achieve more controlled modulation of microbial activity towards desired health outcomes.
异麦芽低聚糖/多聚糖(IMMPs)是一种新型的可溶性膳食纤维,具有益生元潜力,可促进肠道内有益微生物的生长。然而,IMMPs 的作用模式尚不清楚。先前关于 IMMPs 的研究表明,当向大鼠喂食 IMMPs 或在体外发酵过程中使用 IMMPs 时,总细菌(尤其是乳杆菌)增加,并且短链脂肪酸(SCFA)的产量更高。在这里,我们使用宏转录组学来研究具有不同数量α-(1→6)糖苷键的 IMMPs 在与人类粪便接种物孵育时如何影响微生物功能。我们表明,发酵过程中活跃的微生物群落动态取决于所使用的 IMMP 的类型,并且观察到的变化反映在群落基因表达谱中。基于宏转录组分析,拟杆菌、乳杆菌和双歧杆菌是 IMMPs 的主要降解菌,这些细菌的基因表达增加与大量α-(1→6)糖苷键相关。我们还注意到这些细菌的相对丰度增加,并且与 SCFA 合成相关的途径被激活。我们的研究结果可以为针对特定细菌设计益生元以及更有效地控制微生物活性以实现预期健康结果提供基础。